Anthem Inc.

A restricted label can often be an impediment to reimbursement, but Sarepta Therapeutics, Inc. is hoping that the limits on Elevidys, its new gene therapy for Duchenne muscular dystrophy, will press

The Institute for Clinical and Economic Review will examine coverage policies for more than two dozen drugs in the largest formularies of the leading commercial payers in the US to determine whether t

The Institute for Clinical and Economic Review is planning to evaluate US commercial insurance policies for drugs that it considers to be reasonably priced to see how consistently fair prices are rewa

Express Scripts Holding Co. gains significantly more leverage in rebate negotiations through its recently announced collaboration with Blue Cross Blue Shield-owned pharmacy benefit manager Prime Ther